COO Donati Keeps 140,000 Shares in AC Immune, Boosting Investor Confidence Amid Rising Diagnostic Pipeline【news flash】
AC Immune’s COO holds 141k+ shares, backing its PET tracer pipeline and giving investors confidence in the company’s neuro‑degenerative diagnostics, with steady insider alignment and 12%+ recent gains.
3 minutes to read